Search Within

Michael S Baum

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Biostatistics Service (6)
  2. Cardiology (6)
  3. Department of Medicine (6)
  4. Division of Subspecialty Medicine (6)
  5. Epidemiology and Biostatistics (6)
  6. Solid Tumor Oncology Division (5)

More Groups

People
  1. Darren Feldman (4)
  2. Michelle Ginsberg (4)
  3. Robert Motzer (4)
  4. Sujata Patil (4)
  5. Patricia Fischer (3)
  6. Ana Maria Molina (2)

More People

Years
  1. 2012 (2)
  2. 2009 (1)
  3. 2008 (1)
  4. 2007 (1)
  5. 2004 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Cancer (1)
  3. Clinical Cancer Research (1)
  4. Investigational New Drugs (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (1)
  3. Springer (1)
  4. Wiley Blackwell (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma
    Journal Article

    Molina, A. M.; Feldman, D. R.; Voss, M. H.; Ginsberg, M. S.; Baum, M. S.; Brocks, D. R.; Fischer, P. M.; Trinos, M. J.; Patil, S.; Motzer, R. J.
    Cancer (2012)

    Fulltext@MSK | Save
  • Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
    Journal Article

    Molina, A. M.; Feldman, D. R.; Ginsberg, M. S.; Kroog, G.; Tickoo, S. K.; Jia, X.; Georges, M.; Patil, S.; Baum, M. S.; Reuter, V. E.; more...
    Investigational New Drugs (2012)

    Fulltext@MSK | Save
  • Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Feldman, D. R.; Baum, M. S.; Ginsberg, M. S.; Hassoun, H.; Flombaum, C. D.; Velasco, S.; Fischer, P.; Ronnen, E.; Ishill, N.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (Romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes
    Journal Article

    Klimek, V. M.; Fircanis, S.; Maslak, P.; Guernah, I.; Baum, M.; Wu, N.; Panageas, K.; Wright, J. J.; Pandolfi, P. P.; Nimer, S. D.
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Phase I trial of bevacizumab plus sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Feldman, D. R.; Kondagunta, G. V.; Ronnen, E. A.; Fischer, P.; Chang, R.; Baum, M.; Ginsberg, M. S.; Ishill, N.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Cardiac toxicity of 5FU: Does prophylactic telemetry monitoring of patients at increased risk for cardiac toxicity improve safety? A 10-year experience
    Meeting Abstract

    Pizzolato, J.; Baum, M. S.; Steingart, R. M.; Gonen, M.; Minsky, B. D.; Saltz, L. B.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save